Table 1.
Author and Year | |||||
---|---|---|---|---|---|
Histopathology | Copeland, 1996 [25] | Zanotti, 2000 [26] | Zhao, 2006 [24] | Behtash, 2008 [27] | Morikawa, 2014 [25] |
EOC | 37.5% | 33–34% | 50% | 39.1% | 81% |
Invasive EOC | - | - | 22.7% | 21.7% | 20% |
LMP | - | - | 27.3% | 17.4% | 61% |
Germ cell tumor | 45% | 30–33% | 40.9% | 47.8% | 17% |
SCT | 10% | 17–20% | 9.1% | 13% | 2% |
Others | 7.5% | 12–13% | 0 | 0 | 0 |
EOC, epithelial ovarian cancer; LMP, low malignant potential tumor; SCT, sex cord stromal tumor.